JAMFX | SLMCX | JAMFX / SLMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 41 years | - |
Gain YTD | -8.704 | 13.462 | -65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2000 | 125% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 45.5M | 13.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 17.41 | 21.74 | 80% |
Returns for 3 years | -55.89 | -1.89 | 2,950% |
Returns for 5 years | -7.27 | 61.67 | -12% |
Returns for 10 years | 6.31 | 110.78 | 6% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTDZX | 157.16 | 1.34 | +0.86% |
Franklin Biotechnology Discovery Adv | |||
SEKRX | 18.40 | -0.02 | -0.11% |
DWS Emerging Markets Equity R6 | |||
MSCOX | 7.16 | -0.01 | -0.14% |
Morgan Stanley Inst Inception C | |||
RGBLX | 39.23 | -0.10 | -0.25% |
American Funds Global Balanced R1 | |||
CVTCX | 48.19 | -0.15 | -0.31% |
Calamos Growth & Income C |